DPP4 and chronic kidney disease: Given the experimental evidence implicating DPP4 in the pathogenesis of CKD and the demonstrated clinical benefits of DPP4 inhibitors, this study investigated whether uDPP4 activity is associated with an increased risk of CKD progression and mortality in individuals with CKD.